Literature DB >> 10550846

Agreement between self-reported antihypertensive drug use and pharmacy records in a population-based study in The Netherlands.

O H Klungel1, A de Boer, A H Paes, R M Herings, J C Seidell, A Bakker.   

Abstract

From 1987 to 1991, over 36,000 men and women aged 20-59 years have been examined in the Monitoring Project on Cardiovascular Disease Risk Factors in The Netherlands. Classification of the treatment status of hypertensives in this population-based study was based on self-administered questionnaires. In order to assess the accuracy of self-reported antihypertensive drug use we compared the questionnaire information with computerized pharmacy records from a sample of 372 hypertensive subjects. Most antihypertensive drugs that were mentioned in the questionnaire were present in the pharmacy medication history (93%). However, this percentage was less (76%) when a comparison was made with the calculated duration of use based on the number of units prescribed and the directions for use in the pharmacy records. About 94% of the hypertensive subjects who were using an antihypertensive drug according to the pharmacy records, also mentioned at least one antihypertensive drug in the questionnaire. Agreement between self-reported antihypertensive drug use and pharmacy records was consistently high for all classes of antihypertensive drugs. Among 321 (86%) subjects, the number and types of self-reported antihypertensive drugs were exactly the same as in the pharmacy records. In conclusion, the agreement between self-reported antihypertensive drug use and pharmacy records was high, and the self-reported questionnaire information on antihypertensive drug use can be reliably used for the classification of treatment status of hypertensive subjects in this population-based study.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10550846     DOI: 10.1023/a:1008741321384

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  18 in total

1.  Validation of pharmacy records in drug exposure assessment.

Authors:  H S Lau; A de Boer; K S Beuning; A Porsius
Journal:  J Clin Epidemiol       Date:  1997-05       Impact factor: 6.437

2.  Assessing the use of medications in the elderly: methods and initial experience in the Cardiovascular Health Study. The Cardiovascular Health Study Collaborative Research Group.

Authors:  B M Psaty; M Lee; P J Savage; G H Rutan; P S German; M Lyles
Journal:  J Clin Epidemiol       Date:  1992-06       Impact factor: 6.437

3.  Information on drug use in the elderly: a comparison of pharmacy, general-practitioner and patient data.

Authors:  E R Heerdink; H G Leufkens; C Koppedraaijer; A Bakker
Journal:  Pharm World Sci       Date:  1995-01-27

4.  Comparing sources of drug data about the elderly.

Authors:  R E Johnson; W M Vollmer
Journal:  J Am Geriatr Soc       Date:  1991-11       Impact factor: 5.562

5.  Comparison of questionnaire information and pharmacy data on drug use.

Authors:  P A Van den Brandt; H Petri; E Dorant; R A Goldbohm; S Van de Crommert
Journal:  Pharm Weekbl Sci       Date:  1991-04-26

6.  Undertreatment of hypertension in a population-based study in The Netherlands.

Authors:  O H Klungel; A de Boer; A H Paes; J C Seidell; N J Nagelkerke; A Bakker
Journal:  J Hypertens       Date:  1998-09       Impact factor: 4.844

7.  Agreement between women's histories of oral contraceptive use and physician records.

Authors:  M J Rosenberg; P M Layde; H W Ory; L T Strauss; J B Rooks; G L Rubin
Journal:  Int J Epidemiol       Date:  1983-03       Impact factor: 7.196

8.  Agreement between the pharmacy medication history and patient interview for cardiovascular drugs: the Rotterdam elderly study.

Authors:  S I Sjahid; P D van der Linden; B H Stricker
Journal:  Br J Clin Pharmacol       Date:  1998-06       Impact factor: 4.335

9.  Determinants of disease and disability in the elderly: the Rotterdam Elderly Study.

Authors:  A Hofman; D E Grobbee; P T de Jong; F A van den Ouweland
Journal:  Eur J Epidemiol       Date:  1991-07       Impact factor: 8.082

10.  Recall accuracy for prescription medications: self-report compared with database information.

Authors:  S L West; D A Savitz; G Koch; B L Strom; H A Guess; A Hartzema
Journal:  Am J Epidemiol       Date:  1995-11-15       Impact factor: 4.897

View more
  23 in total

1.  The impact of antihypertensive drug groups on urinary albumin excretion in a non-diabetic population.

Authors:  Taco B M Monster; Wilbert M T Janssen; Paul E de Jong; Lolkje T W de Jong-van den Berg
Journal:  Br J Clin Pharmacol       Date:  2002-01       Impact factor: 4.335

2.  The gap between evidence-based medicine and daily practice in the management of paediatric asthma. A pharmacy-based population study from The Netherlands.

Authors:  Tjalling W de Vries; Hilde Tobi; Eric Schirm; Paul van den Berg; Eric J Duiverman; Lolkje T W de Jong-van den Berg
Journal:  Eur J Clin Pharmacol       Date:  2005-12-20       Impact factor: 2.953

3.  Clinical risk management in Dutch community pharmacies: the case of drug-drug interactions.

Authors:  Henk Buurma; Peter A G M De Smet; Antoine C G Egberts
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

4.  Agreement between self-reported and pharmacy data on medication use in the Northern Finland 1966 Birth Cohort.

Authors:  Marianne Haapea; Jouko Miettunen; Sari Lindeman; Matti Joukamaa; Hannu Koponen
Journal:  Int J Methods Psychiatr Res       Date:  2010-06       Impact factor: 4.035

5.  Comparison of Pharmacy Database Methods for Determining Prevalent Chronic Medication Use.

Authors:  Timothy S Anderson; Bocheng Jing; Charlie M Wray; Sarah Ngo; Edison Xu; Kathy Fung; Michael A Steinman
Journal:  Med Care       Date:  2019-10       Impact factor: 2.983

6.  A systematic review of methods for determining cross-sectional active medications using pharmacy databases.

Authors:  Timothy S Anderson; Edison Xu; Evans Whitaker; Michael A Steinman
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-02-13       Impact factor: 2.890

7.  Colon cancer patient information seeking and the adoption of targeted therapy for on-label and off-label indications.

Authors:  Stacy W Gray; Katrina Armstrong; Angela Demichele; J Sanford Schwartz; Robert C Hornik
Journal:  Cancer       Date:  2009-04-01       Impact factor: 6.860

8.  Associations between medication use and homocysteine levels in an older population, and potential mediation by vitamin B12 and folate: data from the B-PROOF Study.

Authors:  Annelies C Ham; Anke W Enneman; Suzanne C van Dijk; Sadaf Oliai Araghi; Karin M A Swart; Evelien Sohl; Janneke P van Wijngaarden; Nikita L van der Zwaluw; Elske M Brouwer-Brolsma; Rosalie A M Dhonukshe-Rutten; Natasja M van Schoor; Tischa J M van der Cammen; M Carola Zillikens; Robert de Jonge; Paul Lips; Lisette C P G M de Groot; Joyce B J van Meurs; André G Uitterlinden; Renger F Witkamp; Bruno H C Stricker; Nathalie van der Velde
Journal:  Drugs Aging       Date:  2014-08       Impact factor: 3.923

9.  Determinants of DNA yield and purity collected with buccal cell samples.

Authors:  D B M A van Wieren-de Wijer; A H Maitland-van der Zee; A de Boer; S V Belitser; A A Kroon; P W de Leeuw; P Schiffers; R G J H Janssen; C M van Duijn; B H C H Stricker; O H Klungel
Journal:  Eur J Epidemiol       Date:  2009-09-17       Impact factor: 8.082

10.  Accuracy of Veterans Affairs databases for diagnoses of chronic diseases.

Authors:  Jasvinder A Singh
Journal:  Prev Chronic Dis       Date:  2009-09-15       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.